Albiglutide: a unique GLP-1 receptor agonist. - Wikidata - awgldk - TriplyDB

Albiglutide: a unique GLP-1 receptor agonist.

Albiglutide: a unique GLP-1 receptor agonist.

http://www.wikidata.org/entity/Q38966029

about

Albiglutide: a unique GLP-1 receptor agonist.

http://www.wikidata.org/entity/Q38966029

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Albiglutide: a unique GLP-1 receptor agonist.

@en

type

label

Albiglutide: a unique GLP-1 receptor agonist.

@en

prefLabel

Albiglutide: a unique GLP-1 receptor agonist.

@en

P1433

Q38966029-BAD1E762-4370-4CC9-AF78-E41FF87A264E

P1476

Q38966029-E27726C9-B5E9-4219-A892-228255C1A79E

P2093

Q38966029-9E7E869A-9C14-4380-A78F-B4164B34DB82

P2860

Q38966029-02828B5D-EB36-464B-9CB1-56410E062301

Q38966029-05B3FD26-3ECD-4795-979D-9CD5CEC020C8

Q38966029-0AAF4EDD-02B8-4D22-AFD8-D82B2BDAF448

Q38966029-0B1DB338-3E04-4C93-94BE-1CE41051F4D4

Q38966029-0D5DA461-65C1-40DC-BCF9-7DE1A7845B34

Q38966029-0DB3C1FA-8A3D-4B21-8991-C0754FFAB38D

Q38966029-0F2D2BEC-54AA-4BCA-9D0B-88E98ABEF14F

Q38966029-15C02007-240D-47D7-BFFB-06C339E61AF4

Q38966029-1771B5DC-518E-4B35-B7B0-BE42443AA0AD

Q38966029-18550C4E-E6BB-42C1-9043-E3FD48A3DD18

P304

Q38966029-9365DC5E-99BF-4F7E-B3DD-13D1E7079D21

P31

Q38966029-4FF78102-9F30-4037-9AA3-39318C3D771F

P356

Q38966029-48F3D5BB-9508-452A-96BE-E21F3CB83A52

P407

Q38966029-5B4C6361-F9C7-4F94-A2F3-9424B486B3CA

P433

Q38966029-B116F4EA-87F8-412C-A5FC-5D3DD8153DD3

P478

Q38966029-F0CAA1FF-F286-4A04-887A-23FF37546AF2

P577

Q38966029-E5AF559D-1292-498B-A83C-2925A2E2FC84

P698

Q38966029-5EBA7091-261C-487E-80F9-E44490E548E2

P356

14712598.2016.1240780

P1433

Expert Opinion on Biological Therapy

P1476

Albiglutide: a unique GLP-1 receptor agonist.

@en

P2093

Marc S Rendell

http://www.w3.org/2001/XMLSchema#string

P2860

DrugBank: a comprehensive resource for in silico drug discovery and exploration

A role for glucagon-like peptide-1 in the central regulation of feeding

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

Pancreatic safety of incretin-based drugs--FDA and EMA assessment

The Physiology of Glucagon-like Peptide 1

Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects.

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults.

The biology of incretin hormones.

P304

1557-1569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14712598.2016.1240780

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27677385

http://www.w3.org/2001/XMLSchema#string